Key Highlights

● AEE closed at $102.09 on 9 October 2026, and the $118.08 consensus target implies upside of about 15.7%.

● The consensus draws on 14 analysts, with targets from $104 to $137, while the second data set shows a $117.88 mean from 17 analysts.

● Market data shows ten Buy and four Hold ratings with no Sell, a Moderate Buy consensus.

● Mizuho cut its target to $113 from $124 on 30 September, and RBC and Morgan Stanley also lowered targets in September.

Ameren Corporation (NYSE:AEE) is a constituent of the S&P 500. The shares closed at $102.09 on Friday 9 October 2026, while the consensus analyst target sits well above that level despite a run of target cuts in late September.

What Is the Latest Analyst Price Target?

Market data reports a consensus twelve-month target of $118.08 from 14 analysts, with a high of $137 and a low of $104. The second data set shows a mean of $117.88 and a median of $118.50 from 17 analysts, with a high of $136 and a low of $104. Its analyst data was last updated on 30 September, so it may not reflect more recent changes.

The two data sets agree closely, and the average of the ten most recent named broker targets, about $117, is consistent with them. Against the $102.09 close, the market data figure of $118.08 implies potential upside of about 15.7%.

What Are Wall Street Analysts Saying?

Sentiment is moderately positive, though recent revisions have leaned downward. Market data shows ten Buy and four Hold ratings with no Sell, a consensus of Moderate Buy. The second data set records nine Strong Buy, two Buy and six Hold.

Late September brought a run of target cuts. Mizuho lowered its target from $124 to $113 on 30 September, keeping Outperform. Scotiabank initiated coverage on 29 September at Sector Perform with a $104 target. RBC cut from $114 to $107 (Sector Perform) on 25 September, and Morgan Stanley from $114 to $108 (Equal Weight) on 18 September. Truist trimmed from $124 to $120 (Buy) on 17 August. In July, JPMorgan raised its target from $126 to $137 (Overweight) and KeyCorp upgraded to Overweight with a $122 target.

What Could Help the Stock Reach the Price Target?

The consensus target suggests analysts see room for recovery from current levels. Supportive regulatory outcomes, steady growth in the rate base and constructive allowed returns are the usual drivers for regulated utilities, as is any easing in borrowing costs. Market data says second-quarter earnings per share of $1.13 beat a $1.08 estimate.

What Could Prevent the Stock Reaching the Target?

The pattern of recent cuts is the main warning sign. Several brokers have lowered targets within a few weeks, which may reflect concerns about interest rates, regulatory decisions or the cost of funding investment plans. Market data also reported quarterly revenue down 5.8% year on year at $2.09 billion, below an estimate of $2.27 billion.

What Should Investors Watch Next?

Items to watch include for further target revisions, regulatory decisions in the company's service territories, updates to its capital plan and moves in interest rates.

Ameren's Upside Case Competes With a Late-September Run of Cuts

Ameren closed at $102.09 on 9 October 2026, and both the $118.08 consensus target and the second data set's $117.88 mean imply upside of roughly 15% or more. Ratings lean positive, with ten Buy and four Hold ratings and no Sell, but Mizuho, RBC and Morgan Stanley all cut targets within about two weeks, and Scotiabank initiated at Sector Perform with a $104 target, the bottom of the range. For a regulated utility, rate-base growth and regulatory outcomes would decide whether the cuts reverse, while quarterly revenue down 5.8% to $2.09 billion, below a $2.27 billion estimate, is the data point working against it.